Cytoflavin–Trekrezan plus training: a 15-mountaineer placebo comparison
V. P. Ganapolsky, V. O. Matytsin, A. E. Kim · 2023 · Experimental and Clinical Pharmacology. 2023;86(11s):37
Related evidence maps: Sports performance ↗ · Military & occupational ↗
Reported findings and study design
Training-associated improvements did not establish an oxygen-consumption benefit from adding the preparation sequence.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Group sizes | Seven placebo; eight preparation-sequence participants; fifteen total. | |
| Peak oxygen consumption per body mass | Placebo +5% (p=0.026); preparation sequence +7% (p=0.011). | Changes within each group; no statistically significant between-group difference reported. |
| Attention-task productivity | Improvement reported in the preparation group, p=0.028. | Exact contrast, raw scores and effect size not clearly supplied. |
The authors identify training as the main factor in physical-endurance improvement. A treatment-specific attention benefit and synergy require stronger comparisons.
Source for the extracted data ↗ · Checked 2026-11-06
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Randomization, allocation concealment and blinding procedures are not described.
- No component-only arms; the preparation sequence does not establish Trekrezan efficacy alone or combination synergy.
- No numerical oxygen-consumption advantage over placebo was established. The attention p-value does not clearly identify its statistical contrast.
- Small conference report; full protocol, adverse events and later replication remain unresolved.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Complete one-page publisher PDF
Review depth: Entire original abstract visually checked
Source access and review scope
Complete publisher abstract, p.37. Related coauthor paper; Shustov is not an author.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Original conference abstract
Citation and original source
Original source: V. P. Ganapolsky, V. O. Matytsin, A. E. Kim. Cytoflavin–Trekrezan plus training: a 15-mountaineer placebo comparison Experimental and Clinical Pharmacology. 2023;86(11s):37 2023.
Molekul research summary: https://molekul.io/research/shustov-network-mountaineers-2023-study. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry